Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CXCR4-targeted 68Ga-Pentixafor PET/CT for Guiding Surgical Treatment of Primary Aldosteronism With Bilateral Adrenal Lesions: Preliminary Results From a Single-center Retrospective Study

NCT06247566 is registered in ClinicalTrials.gov with Central South University as lead sponsor.

NCT NCT06247566
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06247566 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CXCR4-targeted 68Ga-Pentixafor PET/CT for Guiding Surgical Treatment of Primary Aldosteronism With Bilateral Adrenal Lesions: Preliminary Results From a Single-center Retrospective Study
Lead sponsor
Central South University
Phase
Observational
Overall status
Completed
Start date
November 1, 2021
Completion date
July 1, 2023
Enrollment
83 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

primary aldosteronism with bilateral adrenal lesions